ERBB2 and breast cancer: Additionally, BC is categorized into four distinct intrinsic molecular subtypes, each differs in clinical characteristics and treatment requirements: luminal A, luminal B, human epidermal growth factor receptor-2 overexpression (HER-2+), and triple negative (TNBC) [6].